Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
Journal of the National Cancer Institute
|
November 9, 2017
Editorial: Challenges in Quantifying Overdiagnosis
Stuart G Baker, Philip C Prorok, Barnett S Kramer
The New England Journal of Medicine
|
February 14, 2014
The randomized registry trial
Stuart G Baker, Barnett S Kramer, Karen S Lindeman
Biostatistics (Oxford, England)
|
August 20, 2003
A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey
Stuart G Baker, Chia-Wen Ko, Barry I Graubard
BMC Medical Research Methodology
|
May 20, 2004
Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design
Stuart G Baker, Barrett S Kramer, Philip C Prorok
Biometrics
|
March 2, 2005
Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins
Stuart G Baker, Paul Lichtenstein, Jaakko Kaprio, et al.
Trials
|
October 7, 2006
Selecting patients for randomized trials: a systematic approach based on risk group
Andrew J Vickers, Barry S Kramer, Stuart G Baker
Journal of Medical Screening
|
October 18, 2008
Early reporting for cancer screening trials
Stuart G Baker, Barnett S Kramer, Philip C Prorok
The International Journal of Biostatistics
|
June 21, 2011
Clarifying the role of principal stratification in the paired availability design
Stuart G Baker, Karen S Lindeman, Barnett S Kramer
The International Journal of Biostatistics
|
April 14, 2012
Evaluating a new marker for risk prediction using the test tradeoff: an update
Stuart G Baker, Ben Van Calster, Ewout W Steyerberg
Statistics in Medicine
|
August 5, 2015
Latent class instrumental variables: a clinical and biostatistical perspective
Stuart G Baker, Barnett S Kramer, Karen S Lindeman
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
Journal of the National Cancer Institute
|
November 9, 2017
Editorial: Challenges in Quantifying Overdiagnosis
Stuart G Baker, Philip C Prorok, Barnett S Kramer
The New England Journal of Medicine
|
February 14, 2014
The randomized registry trial
Stuart G Baker, Barnett S Kramer, Karen S Lindeman
Biostatistics (Oxford, England)
|
August 20, 2003
A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey
Stuart G Baker, Chia-Wen Ko, Barry I Graubard
BMC Medical Research Methodology
|
May 20, 2004
Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design
Stuart G Baker, Barrett S Kramer, Philip C Prorok
Biometrics
|
March 2, 2005
Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins
Stuart G Baker, Paul Lichtenstein, Jaakko Kaprio, et al.
Trials
|
October 7, 2006
Selecting patients for randomized trials: a systematic approach based on risk group
Andrew J Vickers, Barry S Kramer, Stuart G Baker
Journal of Medical Screening
|
October 18, 2008
Early reporting for cancer screening trials
Stuart G Baker, Barnett S Kramer, Philip C Prorok
The International Journal of Biostatistics
|
June 21, 2011
Clarifying the role of principal stratification in the paired availability design
Stuart G Baker, Karen S Lindeman, Barnett S Kramer
The International Journal of Biostatistics
|
April 14, 2012
Evaluating a new marker for risk prediction using the test tradeoff: an update
Stuart G Baker, Ben Van Calster, Ewout W Steyerberg
Statistics in Medicine
|
August 5, 2015
Latent class instrumental variables: a clinical and biostatistical perspective
Stuart G Baker, Barnett S Kramer, Karen S Lindeman
Page
of 12